| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b567e4f54131fb2d8808ff293880dd9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f463a31682e7d0f195946872f385ebba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-20 |
| filingDate |
2007-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdd5f0bc5fdf7e57d8d521833a22b9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc7c43289b7952087998216c502b2c9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b483d8aecd6fca1ef1b114e8da29cb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b163a73d6cf3bd04b22b34cd5a40d506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66d2c7f2aeec83ccbce3d4b94e43f7c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99471c66b9ed0a239a71ce260a4bba85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca64bd3d626896e073d6313d46500780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4de3f0ae177ed0561155558448266aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff09b47ddf4c770ef588a3bebca794b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cb48b0853158372930a187b32e000b6 |
| publicationDate |
2008-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1889831-A2 |
| titleOfInvention |
Diazenedicarboxamides as inhibitors of D-alanine: D-alanine ligase (Ddl) |
| abstract |
This invention belongs to the field of pharmaceutical chemistry and relates to new diazenedicarboxamides as inhibitors of D-alanine:D-alanine ligaze (Ddl), to procedures for their preparation and pharmaceutical preparations containing the same. Compounds of general formula I:n nand the pharmaceutically acceptable salts are described. The appropriate substituents are clearly presented in the body of the text and in claims. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102408359-A |
| priorityDate |
2006-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |